Enzyme Kinetics, Regulation, Inhibition, and Zymogen Activation

Enzyme Kinetics and Substrate Saturation

• Enzyme Action and Kinetic Analogy:

  • Enzymes function as biological catalysts that convert substrate molecules into chemical products.
  • Increasing enzyme concentration adds more functional active sites to the system, which directly increases the reaction velocity ($V$).

• Substrate Concentration ($[S]$) and Reaction Velocity ($V$):

  • At low substrate concentrations, increasing substrate concentration ($[S]$) increases the reaction velocity ($V$).
  • This initial increase occurs because free, unoccupied active sites remain available on the enzyme molecules to process incoming substrate.

• Enzyme Saturation and Reaction Velocity Plateau:

  • As substrate concentration continues to increase, the reaction rate eventually levels off and reaches a maximum plateau ($V_{max}$).
  • The plateau occurs due to complete enzyme saturation, meaning every active site across all enzyme molecules is occupied and operating at maximum catalytic capacity.
  • Once saturated, adding additional substrate does not increase reaction velocity because no unmapped or free active sites remain available.

• Michaelis Constant ($K_m$):

  • $K_m$ measures the affinity of an enzyme for its specific substrate.
  • $K_m$ corresponds to the substrate concentration at which the reaction velocity reaches half of its maximum value ($\frac{1}{2}V_{max}$).

Factors Affecting Reaction Velocity: Temperature, pH, and Concentration

• Enzyme Density and Concentration:

  • Increasing enzyme density or concentration increases overall reaction velocity.
  • Reducing enzyme density decreases overall reaction velocity by limiting catalytic capability.

• Temperature Effects on Enzyme Function:

  • Moderate Kinetic Energy Increase:
    • Slightly increasing system temperature adds kinetic energy to reacting molecules.
    • This kinetic energy helps satisfy the required activation energy ($E_a$), accelerating the reaction rate.
  • Thermal Denaturation:
    • Excessive temperature elevation disrupts structural bonds, causing denaturation and inactivation of native body enzymes.
  • Biological vs. Laboratory Thermal Tolerance:
    • In human physiology, fever-level temperatures are high enough to begin denaturing body proteins.
    • In laboratory assays (such as Polymerase Chain Reaction / PCR), specialized enzymes are utilized that withstand high thermal conditions between 90^\text{--}100^\text{ }^\text{o}\text{C}.
  • Hypothermia:
    • Hypothermic conditions reduce system kinetic energy.
    • This reduction slows molecular movement and increases the required activation energy ($E_a$), significantly slowing catalytic rates.

• pH Sensitivity:

  • Enzymes possess specific optimal pH ranges required for biological activity.
  • Pepsin: Operates optimally in highly acidic pH conditions.
  • Small Intestine Enzymes: Function optimally in more neutral pH environments.

Reversible vs. Irreversible Enzyme Inhibition

• Irreversible Inhibition:

  • Occurs when an inhibitor binds permanently to an enzyme via covalent or high-affinity bonds.
  • Permanently compromises and inactivates the enzyme for the rest of its functional lifespan.
  • Example: Heavy metal toxicities, such as lead binding permanently to functional groups on enzymes.

• Reversible Inhibition:

  • Occurs when an inhibitor binds to an enzyme via non-covalent, reversible interactions.
  • Inhibitors can freely dissociate from the enzyme, allowing catalytic functionality to recover.
  • Divided into competitive inhibition and non-competitive (allosteric) inhibition.

Competitive Inhibition Mechanics and Kinetics

• Active Site Binding Mechanism:

  • Competitive inhibitors bind directly to the primary active site of the enzyme.
  • Because the inhibitor occupies the active site, the natural substrate is physically prevented from binding.

• Impact on Kinetic Parameters ($K_m$ and $V_{max}$):

  • Apparent Enzyme Affinity ($K_m$): The presence of a competitive inhibitor increases the apparent $K_m$ value (meaning it decreases apparent substrate affinity).
  • Maximum Velocity ($V_{max}$): The maximum velocity remains completely unchanged.

• Lineweaver-Burk Plot Characteristics:

  • Y-intercept ($\frac{1}{V_{max}}$): The plot line intersects the y-axis at the exact same point as an uninhibited reaction, demonstrating that $V_{max}$ is uncompromised.
  • X-intercept ($-\frac{1}{K_m}$): The reciprocal value crossing the x-axis shifts closer to the origin, reflecting an increased $K_m$ value.

• Reversibility by Substrate Overcoming:

  • Competitive inhibition can be overcome by adding excess substrate ($[S]$).
  • High concentrations of substrate outcompete the inhibitor for active site occupancy, restoring maximal reaction velocity ($V_{max}$).

Non-Competitive and Allosteric Inhibition Mechanics and Kinetics

• Allosteric Site Binding Mechanism:

  • Non-competitive inhibitors bind to a secondary site on the enzyme known as the allosteric site.
  • The inhibitor can bind to either the free enzyme or the enzyme-substrate ($ES$) complex.
  • Binding at the allosteric site induces a conformational change that prevents the catalytic reaction from moving forward, regardless of substrate binding.

• Impact on Kinetic Parameters ($K_m$ and $V_{max}$):

  • Apparent Enzyme Affinity ($K_m$): Remains unchanged because substrate binding to the active site is unimpeded.
  • Maximum Velocity ($V_{max}$): Is reduced because the total population of functionally active enzymes is lowered.

• Lineweaver-Burk Plot Characteristics:

  • X-intercept ($-\frac{1}{K_m}$): Intersects the x-axis at the exact same position as the uninhibited reaction, confirming $K_m$ is unchanged.
  • Y-intercept ($\frac{1}{V_{max}}$): Crosses higher on the y-axis, indicating a decreased maximum velocity ($V_{max}$).

• Inability to Overcome via Substrate Addition:

  • Increasing substrate concentration ($[S]$) cannot overcome non-competitive inhibition because the inhibitor binds to a separate site from the substrate.

Questions and Discussion

• Question: Does a competitive inhibitor have a higher affinity for the active site than the substrate?
• Answer: Many therapeutic drugs are explicitly engineered to possess higher binding affinity for the active site than natural substrates. This higher affinity allows them to compete more effectively and exert strong therapeutic inhibition.

Enzyme Cofactors and Coenzymes

• Classification of Cofactors:

  • Cofactors are non-protein helper molecules required for enzyme activity.
  • Coenzymes: Small organic non-protein molecules.
  • Essential Ions / Inorganic Cofactors: Inorganic metal ions required for structural or catalytic function.

• Dietary Requirement for Vitamins:

  • Human metabolic pathways cannot synthesize most essential organic vitamins.
  • Vitamins must be obtained via the diet to serve as coenzymes or coenzyme precursors.

Zymogens (Proenzymes) and Proteolytic Activation

• Definitions and Nomenclature:

  • Zymogens (Proenzymes): Inactive enzyme precursors that require structural cleavage to become active.
  • Suffix "-ogen": Designates an inactive zymogen (e.g., pepsinogen is the inactive zymogen of active pepsin).
  • Prefix "pro-": Designates an inactive zymogen (e.g., proelastase is the inactive zymogen of active elastase).

• Synthesis and Secretory Pathway:

  • Zymogens are synthesized in inactive forms inside cells to prevent premature destruction of cellular structures.
  • Traverse the cellular secretory pathway through the Golgi apparatus and are packaged into secretory vesicles before cellular release.

• Mechanism of Irreversible Proteolytic Activation:

  • Activation occurs via proteolytic cleavage, where a specific blocking peptide segment is excised from the proenzyme.
  • Cleavage exposes the active site, allowing the substrate to enter and undergo catalysis.
  • This process is completely irreversible; once the peptide segment is cut off, it cannot be re-attached. The active enzyme remains active until degraded.

• Physiological Protection Against Autolysis:

  • Zymogen production prevents autolysis (self-digestion) of host tissues (such as pancreatic tissue or gastric glands).
  • Enzymes remain safely inactive until reaching their designated external lumen (such as the stomach or small intestine), where localized environmental shifts trigger activation.

Gastric Secretions and Pepsinogen Activation

• Gastric Gland Cell Types and Secretions:

  • Parietal Cells: Secrete hydrochloric acid ($\text{HCl}$) into the gastric cavity.
  • Chief Cells: Secrete the inactive zymogen pepsinogen.

• Activation Mechanism in the Stomach:

  • Chief cells release pepsinogen into the gastric cavity alongside $\text{HCl}$ produced by parietal cells.
  • The low pH created by the acidic environment induces structural cleavage of pepsinogen into active pepsin.
  • Active pepsin digests dietary proteins in the stomach cavity without damaging the producing cells of the gastric glands.